BioCentury
ARTICLE | Company News

CorMedix management update

January 7, 2013 8:00 AM UTC

CorMedix Inc. (NYSE-M:CRMD), Summit, N.J. Business: Renal, Cardiovascular Departing: Mark Klausner as CMO, effective Feb. 28 Hired: Antony Pfaffle, a director, as acting CSO Promoted: Randy Milby to C...